An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report

Systemic chemotherapies are the primary treatment options for patients with unresectable and metastatic intrahepatic cholangiocarcinoma (ICC), but the effectiveness of current systemic therapies is limited. The development of targeted-therapy has changed the treatment landscape of ICC, and comprehen...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Senmiao, Li, Dianhe, Huang, Yongye, Lu, Guojie, Tian, Ying, Zhong, Xuefeng, Zheng, Yating, Huang, Mengli, Huang, Fuxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477974/
https://www.ncbi.nlm.nih.gov/pubmed/37675235
http://dx.doi.org/10.3389/fonc.2023.1191646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477974/
https://www.ncbi.nlm.nih.gov/pubmed/37675235
http://dx.doi.org/10.3389/fonc.2023.1191646

Ejemplares similares